Clear Harbor Asset Management’s Context Therapeutics CNTX Stock Holding History

Clear Harbor Asset Management’s Portfolio CNTX Stock Details CNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$51.4K	Hold	92,804	–	–	﹤0.01%	443
2026 Q1	$243K	Hold	92,804	–	–	0.02%	392
2025 Q4	$136K	Hold	92,804	–	–	0.01%	423
2025 Q3	$89.9K	Buy	92,804 +35,000	+61%	+$28.4K	0.01%	410
2025 Q2	$37.9K	Hold	57,804	–	–	﹤0.01%	405
2025 Q1	$35.4K	Hold	57,804	–	–	﹤0.01%	403
2024 Q4	$60.7K	Buy	57,804 +21,804	+61%	+$37.7K	﹤0.01%	385
2024 Q3	$70.6K	Hold	36,000	–	–	0.01%	359
2024 Q2	$72.2K	Hold	36,000	–	–	0.01%	353
2024 Q1	$49.7K	Hold	36,000	–	–	﹤0.01%	356
2023 Q4	$40.7K	Hold	36,000	–	–	﹤0.01%	361
2023 Q3	$54.4K	Hold	36,000	–	–	0.01%	340
2023 Q2	$57.6K	Buy	+36,000	New	+$30.6K	0.01%	347

Other funds holding CNTX

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BOCH

Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Clear Harbor Asset Management's CNTX Position: Q2 2026 in Review

Clear Harbor Asset Management held its Context Therapeutics (CNTX) position steady in Q2 2026 at 92,804 shares worth $51.4K. The position accounts for ﹤0.01% of the portfolio, ranked #443.

Clear Harbor Asset Management first reported a position in CNTX in Q2 2023 and has held it in 13 quarters since. The position peaked at $243K in Q1 2026. 43 funds tracked by Wall St. Rank hold CNTX as of Q2 2026.

Clear Harbor Asset Management held 92,804 shares of Context Therapeutics worth $51.4K as of Q2 2026.
Clear Harbor Asset Management left its Context Therapeutics share count unchanged in Q2 2026.
Context Therapeutics made up ﹤0.01% of Clear Harbor Asset Management's portfolio in Q2 2026, its #443 holding.
Clear Harbor Asset Management first reported a position in Context Therapeutics in Q2 2023 and has held it in 13 quarters since.
Clear Harbor Asset Management's Context Therapeutics position peaked at $243K in Q1 2026.
43 funds tracked by Wall St. Rank held Context Therapeutics as of Q2 2026.

Based on Clear Harbor Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.